Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 3 studies | 22% ± 5% |
Insufficient scRNA-seq data for expression of FPGT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 890.35 | 459 / 459 | 100% | 16.95 | 1118 / 1118 |
ovary | 100% | 897.81 | 180 / 180 | 100% | 9.28 | 430 / 430 |
uterus | 100% | 834.38 | 170 / 170 | 100% | 11.49 | 459 / 459 |
esophagus | 100% | 749.46 | 1444 / 1445 | 100% | 11.45 | 183 / 183 |
prostate | 100% | 774.04 | 245 / 245 | 100% | 12.62 | 501 / 502 |
pancreas | 99% | 558.66 | 326 / 328 | 100% | 9.28 | 178 / 178 |
thymus | 100% | 999.26 | 653 / 653 | 99% | 11.09 | 601 / 605 |
bladder | 100% | 760.81 | 21 / 21 | 99% | 10.55 | 500 / 504 |
lung | 99% | 644.30 | 572 / 578 | 100% | 11.77 | 1154 / 1155 |
kidney | 100% | 751.85 | 89 / 89 | 99% | 11.47 | 889 / 901 |
intestine | 100% | 797.25 | 966 / 966 | 98% | 10.30 | 517 / 527 |
liver | 99% | 544.88 | 224 / 226 | 99% | 7.77 | 401 / 406 |
stomach | 100% | 657.62 | 358 / 359 | 98% | 10.19 | 280 / 286 |
brain | 98% | 365.72 | 2601 / 2642 | 99% | 9.25 | 699 / 705 |
adrenal gland | 100% | 924.02 | 258 / 258 | 97% | 6.64 | 222 / 230 |
skin | 100% | 853.99 | 1808 / 1809 | 92% | 9.84 | 434 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 5.97 | 29 / 29 |
spleen | 100% | 797.49 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.02 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.08 | 1 / 1 |
adipose | 100% | 887.53 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 797.98 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 366.05 | 791 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 613.23 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 73% | 434.40 | 678 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 55% | 3.32 | 44 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006004 | Biological process | fucose metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005525 | Molecular function | GTP binding |
GO_0003824 | Molecular function | catalytic activity |
GO_0047341 | Molecular function | fucose-1-phosphate guanylyltransferase activity |
Gene name | FPGT |
Protein name | Fucose-1-phosphate guanylyltransferase Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30) (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase) Fucose-1-phosphate guanylyltransferase isoform 2 FPGT protein Fucose-1-phosphate guanylyltransferase isoform 3 |
Synonyms | hCG_2039595 GFPP |
Description | FUNCTION: Catalyzes the formation of GDP-L-fucose from GTP and L-fucose-1-phosphate . Functions as a salvage pathway to reutilize L-fucose arising from the turnover of glycoproteins and glycolipids . . |
Accessions | A0PJA8 ENST00000370894.9 [O14772-3] H0YDF0 ENST00000370898.9 A0A0S2Z5C6 A0A0S2Z4Z3 ENST00000529485.5 ENST00000482102.2 ENST00000472069.1 ENST00000534056.5 [O14772-2] A0A0S2Z4P4 E9PK10 E9PMK0 ENST00000467578.7 E9PMM4 O14772 |